Vicor Technologies Receives Allowance of United States Patent Application Related to Its State Dependent Drug Development Platform
BOCA RATON, FL--(Marketwire - May 4, 2010) - David H. Fater, CEO of Vicor Technologies, Inc. (OTCBB: VCRT), today announced the Company received a Notice of Allowance for its U.S. Patent Application No. 10/359,363 for a method of treating ischemia through administration of a biologic identified through Vicor's state dependent drug discovery platform. Upon issuance, this patent will provide Vicor with patent protection for methods of using a peptide to treat infarctions, such as cardiac or cerebral infarctions.
View More : http://www.marketwire.com/mw/release.do?id=1158321&sourceType=3
|